Takeshi Shimizu, Takeo Usui, Makoto Fujikura, Makoto Kawatani, Tomoharu Satoh, Kiyotaka Machida, Naoki Kanoh, Je-Tae Woo, Hiroyuki Osada, Mikiko Sodeoka
Index: Bioorg. Med. Chem. Lett. 18(13) , 3756-60, (2008)
Full Text: HTML
Various derivatives of reveromycin A, an inhibitor of eukaryotic cell growth, and spirofungin A, focusing on the 5S hydroxyl group and C18 hemisuccinyl group, were synthesized and their inhibitory effects on both the isoleucyl-tRNA synthetase activity and the survival of osteoclasts, and activities on the morphological reversion of src(ts)-NRK cells were examined. It was found that 2,3-dihydroreveromycin A is the promising derivative of reveromycin A based on the activity and stability.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Reveromycin A
CAS:134615-37-5 |
C36H52O11 |
|
Development and application of bioprobes for Mammalian cell ...
2003-05-01 [Curr. Med. Chem. 10(9) , 727-32, (2003)] |
|
Osteoclast-targeting small molecules for the treatment of ne...
2009-11-01 [Cancer Sci. 100(11) , 1999-2005, (2009)] |
|
Pharmacological topics of bone metabolism: antiresorptive mi...
2008-04-01 [J. Pharmacol. Sci. 106(4) , 547-54, (2008)] |
|
Creation of novel reveromycin derivatives by alcohol-added f...
2013-04-01 [J. Antibiot. 66(4) , 247-50, (2013)] |
|
Stabilization of tooth movement by administration of reverom...
2013-09-01 [Am. J. Orthod. Dentofacial Orthop. 144(3) , 368-80, (2013)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
